Covid induced thyroiditis: a case report

Tahir Ghaffar; Bakht Babar; Mian Sameer Ahmed; Adnan Rehman; Sabeen Zia; Azizul Hasan Aamir

No Detail Found!

Covid induced thyroiditis: a case report

Author(s)

Tahir Ghaffar Department of Diabetes and Endocrinology, Medical Teaching Institution Hayatabad Medical Complex,Peshawar,Pakistan

Bakht Babar Department of Diabetes and Endocrinology, Medical Teaching Institution Hayatabad Medical Complex,Peshawar,Pakistan

Mian Sameer Ahmed Department of Diabetes and Endocrinology, Medical Teaching Institution Hayatabad Medical Complex,Peshawar,Pakistan

Adnan Rehman Department of Diabetes and Endocrinology, Medical Teaching Institution Hayatabad Medical Complex,Peshawar,Pakistan

Sabeen Zia Institute of Radiology and Nuclear Medicine (IRNUM), Peshawar, Pakistan

Azizul Hasan Aamir Department of Diabetes and Endocrinology, Medical Teaching Institution Hayatabad Medical Complex,Peshawar,Pakistan

Abstract

INTRODUCTION: Thyroiditis is one of the manifestations of novel Covid-19 virus. Thyroid function test (TFTs) shows typical features of hyperthyroidism. Inflammatory markers [erythrocyte sedimentation rate (ESR), C reactive protein (CRP) and serum ferritin] and thyroid scan give clue to the diagnosis. Up till now very few cases of subacute thyroiditis (SAT) due to Covid-19 have been reported CASE DESCRIPTION: We present a case of 39-year-old female with no personal or family history of thyroid disorder presented with features suggestive of thyrotoxicosis along with pain in the neck, odynophagia and intermittent fever after recovering from covid-19 recently i.e. 2 weeks before the onset of symptoms. TFTs revealed high triiodothyronine-T3 (1.8 hg/ml) and thyroxine-T4 (2.66 hg/dl) and low TSH (<0.04 uIU/ml). Thyroid scan revealed decrease uptake, ESR was 115 mm/hour, CRP was 48 mg/L and serum ferritin was 740hg/ml. She was started on non-steroidal anti-inflammatory drugs, steroids and beta blocker. Four weeks later she reverted back with the resolution of symptoms and normal TFTs. CONCLUSION: Early recognition and timely management of SAT with anti-inflammatory therapy can help in successful management of the disease.

Publication Details

Page(s) 14-0

DOI DOI not available

Published Journal: Khyber Medical University Journal, Volume: 13, Issue: 1, Year: 2021

Request the full text from PASTIC

Keywords

COVID-19 (MeSH), C-reactive protein (MeSH), Triiodothyronine (MeSH), Thyroid Hormones (MeSH), Thyroxine (MeSH), Thyroiditis (MeSH), Thyrotoxicosis (MeSH), Blood Sedimentation (MeSH)

Citations

Downloads

Views